Shkreli Cuts $1.5M Deal To End KaloBios Investors' Suit
KaloBios Pharmaceuticals Inc. shareholders asked a California federal judge on Wednesday to approve a $1.5 million deal to resolve claims against former KaloBios CEO Martin Shkreli, marking an end to a...To view the full article, register now.
Already a subscriber? Click here to view full article